Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
Frontiers | JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
Viruses | Free Full-Text | JAK-STAT Pathway: A Novel Target to Tackle Viral Infections
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
JCI - The suppressor of cytokine signaling–1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury
The role of JAK/STAT signaling pathway and its inhibitors in diseases - ScienceDirect
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
JAK-STAT Signaling Pathway - YouTube
JAK inhibitors for Atopic Dermatitis – STAT!
Targeting the JAK/STAT pathway in solid tumors
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
APExBIO - JAK/STAT Signaling - Signaling Pathways
JCI - JAK inhibitors in autoinflammation
The Potential of JAK/STAT Pathway Inhibition as a New Treatment Strategy to Control Cytokine Release Syndrome in COVID-19 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19: Trends in Pharmacological Sciences
Cells | Free Full-Text | Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
Ruxolitinib | CAS 941678-49-5 | InvivoGen
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors - Welsch - 2017 - European Journal of Immunology - Wiley Online Library
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia | Inflammation and Regeneration | Full Text
Hypoglycaemia following JAK inhibitor treatment in patients with diabetes | Annals of the Rheumatic Diseases
JAK/STAT signaling in hematological malignancies | Oncogene
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
